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Abstract
Background: Colorectal cancer (CRC) is one of the leading causes of death among Americans
and Kentuckians. Most colorectal cancers are slow growing, making regular colorectal cancer
screening increasingly important to decrease morbidity and mortality. Although of this
importance, there is low screening rates. Thus, the need to explore all colorectal screening
options.
Purpose: The purpose of this project was to increase the number of patients screened for
colorectal cancer by providing education on colorectal cancer and screening options in a primary
care setting.
Methods: The design of the study was a 2 group quasi-experimental practice improvement
project using a post-test educational survey and chart review. The intervention was a tailored
educational pamphlet developed by the Kentucky Cancer Program with information regarding
CRC and types of CRC screening. The intervention was given to patients 50 to 75 years old who
were being seen at the clinic that day and due for CRC screening. The control group (n=15)
consisted of patients who were due for CRC screening and received usual care at the clinic. A
three-question post-test was used to assess patient knowledge changes and likelihood of
screening post intervention. Chart reviews assessed completion status of CRC screening within
four months following implementation of education.
Results: The project had 17 participants. There was a 100% success rate in participants being
able to review the pamphlet and 88.2% (n=15) of participants reported that they learned
something new about CRC or screening options. Participants ranked their likelihood of
completing CRC screening as a 5.59 out of 10, with 10 being very likely. Overall, There was no
significant difference in CRC screening rates between the control and intervention groups.
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Conclusions: The findings of this QI project show that tailored patient education pamphlets did
not have a significant impact on the rates of CRC screening at this clinic although CRC
knowledge did increase among those in the intervention group.
Keywords: Colorectal cancer, tailored patient education, colorectal cancer screening
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Effects of Tailored Colorectal Cancer Patient Education on Colorectal Cancer Screening Rates in
an Urban Kentucky Clinic
Background and Significance
Introduction
In the state of Kentucky, colorectal cancer (CRC) is the fourth leading cause of cancer
and the fourth leading cause of death due to cancer, yet only 68 percent of people aged 50-75
received CRC screening in 2018 (CDC, 2017; American Cancer Society, 2020). Colorectal
cancer is also the third leading cause of cancer-related deaths in the United States, with an
increased risk in men, African Americans, the Appalachian population, and rural areas
(American Cancer Society, 2014). Therefore, a very prevalent issue in today’s healthcare that
needs to be addressed is the prevalence of colorectal cancer related death in Kentucky.
Screening can decrease incidence and increase survival by detecting and removing
precancerous growths and detecting early stages of the disease when treatment options are more
successful (American Cancer Society, 2020). Consequently, the main consequence of this issue
is possible death due to lack of screening. Failure to screen or screening at inappropriate intervals
accounts for 67.8% of patients who died from CRC (Doubeni, et al., 2019). According to the
American Cancer Society, the recommendation for CRC screening is for regular screening in
average risk adults aged 45 to 75 years (2020). Despite these recommendations and statistics,
there suboptimal percentage of 50 to 75-year-olds getting adequate CRC screening (American
Cancer Society, 2020).
Most colorectal malignancies are slow growing, typically, progressing through a course
from precancerous polyps to invasive cancer and eventually advanced-staged disease. This slow
growth makes regular CRC screening increasingly important to decrease morbidity, mortality,
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and cost of treatment (American Cancer Society, 2020; Doubeni, et al., 2019). Total health care
costs in the first year after the diagnosis of CRC can range from $36,000 to $74,000 depending
on the stage of the disease (Green, & Meenan, 2020). The cost of screening and diagnostic
services per person for a colonoscopy was $1,150 and $304 for FIT/FOBT-based screening
(Subramanian, Tangka, Hoover, Cole-Beebe, Joseph, & DeGroff, 2019). Subsequently,
screening is very cost effective when compared to the cost of CRC treatment for the first year
alone. The cost of adequate CRC screening and early detection of CRC far outweigh the cost
associated with years of CRC treatment.
To increase screening rates, it is important to educate patients on all forms of screening
including less invasive CRC screening options. Within Kentucky, 70% of those 50 years and
older for CRC screening report being up to date on CRC screening (American Cancer Society,
2020). According to the National Center for Health Statistics, Division of Health Interview
Statistics (2019), within the United States 66% of people under 50 years old were up to date on
CRC screening and 67% of those 50 to 75 years old were up to date. Among those 50 years and
older, 61% of people reported completion of a colonoscopy in the past 10 years, 3% reported
having a sigmoidoscopy and 1% reported CT colonography in the past 5 years. Comparatively,
around 11% reported completion of a stool test, 9% reported completion of a FIT or FOBT
screening in the past year and 3% reported stool DNA testing in the past 3 years (National Center
for Health Statistics, Division of Health Interview Statistics, 2019).
Colorectal Cancer Screening Options
There are many recommended methods for CRC screening by the American Cancer
Society including invasive and noninvasive options. All screening methods have similar
capability to improve life expectancy when preformed at the appropriate time intervals with
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appropriate follow up care (American Cancer Society, 2020). The American Cancer Society
recommends that patients be given education on the benefits and risks associated with each test
and have the ability to choose the best test for their health history, preferences and advice from
their health care provider as needed (American Cancer Society, 2020). It has been proven that
offering patients different testing options noticeably increases adherence to screening
recommendations (American Cancer Society, 2020; Gupta, et al., 2013). Due to this, the
American Cancer Society (ACS) and US Prevention Services Task Force (USPSTF) guidelines
do not emphasize any one test over another but stress that all recommended tests can help save
lives ( 217, 224). Screening modalities recommended for use include colonoscopy, flexible
sigmoidoscopy, computed tomographic colonography, guaiac-based fecal occult blood test, fecal
immunochemical test, and multitargeted stool DNA test.
Colonoscopy is the most used screening test in the US and is typically performed by a
gastroenterologist or surgeon and scores the highest in performance and complexity (American
Cancer Society, 2020). This screening option allows the provider to obtain a direct visual
examination of the entire colon as well as the rectum and can be used alone or as follow up for
an abnormal finding during other forms of screening. It has been shown that colonoscopy can
reduce CRC incidence by about 40% and mortality by 60% (American Cancer Society, 2020;
Zauber, et al., 2012; Doubeni, et al., 2018). This test, if normal, can be repeated every 10 years
(American Cancer Society, 2020). Some limitations of colonoscopy include cost of screening,
decreased visibility if bowel is not completely cleansed, more invasive (requiring sedation and
possibly requiring patient to miss a day of work), and highest risk of bowel tears or infections
compared to other tests (American Cancer Society, 2020).
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Flexible sigmoidoscopy was a very common screening option before the year 2000
although availability is now limited due mostly to the replacement by colonoscopy (American
Cancer Society, 2020). Sigmoidoscopy is very similar to a colonoscopy although sigmoidoscopy
can only visualize the rectum and the distal one-third of the colon and must be repeated more
often (every 5 years, if normal) (American Cancer Society, 2020). Bowel preparation is less
intense than a colonoscopy only requiring use of an enema prior to screening. Sedation is not
required for a sigmoidoscopy and is typically preformed in a general health care providers office
(American Cancer Society, 2020). If there are abnormalities present the patient is then referred
for a colonoscopy in order to view and examine the entire colon. Sigmoidoscopies are associated
with about 20-25% reduction in CRC incidence and a 25-30% reduction in mortality due to CRC
(American Cancer Society, 2020).
Computed tomographic colonography (CTC) is similar to colonoscopy in that it is a
visual examination. This screening option is an imaging procedure that provides 2 or 3
dimensional views of the entire colon with the use of a CT machine (American Cancer Society,
2020). CTC is a quick (10-15 minutes) noninvasive screening with few complications and no
sedation needed, making it more appealing. The patient is still required to complete a full bowel
cleansing prior to aid in better image and the colon is filled with air before scanning begins
(American Cancer Society, 2020). Studies show that CTC screening is similar in performance to
colonoscopy for the detection of invasive cancer and advanced adenomas (de Haan, van Gelder,
Graser, Bipat, Stoker, 2011). If negative, CTC screening is recommended to be repeated every
five years. Limitations associated with CTC include inability to remove polyps or perform
biopsies, exposure to low-dose radiation, and it is not covered by all insurance plans (American
Cancer Society, 2020).
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Guaiac-based fecal occult blood test (gFOBT) is another option used for CRC screening
that is low cost and non-invasive. This screening option falls under the umbrella of stool testing
using a chemical reaction to detect any form of blood in the stool. Most polyps will be missed
when this option is used because this screening does not allow the provider to obtain a direct
visual examination of the colon (American Cancer Society, 2020). Bowel cleansing and sedation
are not necessary for this form of testing allowing the patient to perform the screening at home,
resulting in less stress on the patient (American Cancer Society, 2020). Due to the sporadic
bleeding patterns of cancers or adenomas stool samples are collected from patients using
multiple consecutive bowel movements to aid in accurate results (American Cancer Society,
2020). This test is required annually, although, if there is a positive result the patient is then
referred for a colonoscopy for further testing. Regular use of gFOBT was shown to reduce risk of
CRC mortality by 32% and reduce CRC incidence by 20% (American Cancer Society, 2020).
Fecal immunochemical test (FIT) is another low-cost, non-invasive screening option that
falls under the umbrella of stool testing. This screening tests antibodies against hemoglobin to
specifically detect human blood in the stool and is twice as likely as gFOBT to detect both
advanced adenomas and cancers (Hassan, et al., 2012; Robertson, et al., 2016). Bowel cleansing
and sedation are not necessary for this form of testing allowing the patient to perform the
screening at home. FIT testing similarly to gFOBT testing requires annual testing, multiple stool
samples, can miss polyps, and has the possibility of false positive results (American Cancer
Society, 2020).
Multitargeted Stool DNA test (Cologuard) is a form of stool testing that not only detects
blood in the stool but also multiple genetic mutations in the DNA of cells that are shed into the
stool by large adenomas and CRC (American Cancer Society, 2020). Cologuard has been shown
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to detect cancer and precancerous lesions more often than FIT but also results in more false
positive results leading to unnecessary colonoscopies (Imperiale, et al., 2014). This screening
form is newer, and data is still being collected to examine the performance in community settings
although it is still recommended by ACS and USPSTF. Cologuard is covered by Medicare, but
some private insurances may not cover the screening although patient navigation services are
built into the cost of the test including phone call and letter reminders to support test completion
(American Cancer Society, 2020). Similarly to FIT and gFOBT testing, bowel cleansing and
sedation are not necessary enabling the patient to perform the screening at home on their own
(American Cancer Society, 2020). In contrast to FIT and gFOBT testing, Cologuard only
requires one stool sample and can be repeated every three years, although, it does come at a
higher cost than FIT and gFOBT is not covered by insurance (American Cancer Society, 2020).
Although colonoscopy is the gold standard, many patients are hesitant because of the
invasive nature of a colonoscopy. With increased education on all forms of screening, CRC
screening can be viewed as more appealing to patients allowing them to make an educated
decision on which screening form they would prefer to complete and increasing compliance
(American Society of Gastrointestinal Endoscopy, 2017).
Context, Scope, and Consequences of the Problem
The population impacted by this issue include individuals 50-75 years of age who are due
for CRC screening. This project more specifically focused on patients at a University of
Kentucky academic Family Medicine clinic that is home to several primary care and specialty
outpatient providers with 23 family and community medicine providers. A unique aspect of the
Family and Community Medicine clinic is that they facilitate a quality improvement (QI)
program for residents and nurse practitioner students. This program allows students to learn the
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quality improvement process and put these newly learned tools to work to address a QI measure
determined by the clinic. During the program, students were divided into groups to address
multiple clinic quality measures through QI projects. Regular meetings were held to discuss the
progress of all the QI projects and how to work through the next step of the process. Smaller
groups also met to plan their group’s QI project and implementation.
One quality measure focus was the rate of CRC screening throughout the clinic. The
clinic’s goal was to have 65% of patients completing CRC screening. In April of 2018, the rate
was 56.93%, and as of October 1st, 2020, that number increased to 63.8%. Although this is a
positive change, there is still room to improve.
Current Evidence-Based Intervention
Although colonoscopy is gold-standard for CRC screening, other reliable forms of
screening are available to patients. One form of CRC screening, Cologuard, stand out to patients
because it is less invasive, simple, and covered by most insurances including Medicare (Ahlquist,
2019). Among Medicare patients unwilling to undergo colonoscopy screening, there was an 88%
compliance rate with fecal testing (Ahlquist, 2019). Among previously nonadherent patients,
88.3% of patients were adherent with Cologuard over 12 months and 96.1% of patients who had
a positive Cologuard test underwent follow up colonoscopy (Prince, Lester, Chiniwala, &
Berger, 2017). On the other hand, when patients were recommended to complete colonoscopy
screening, adherence rates were much lower (38%) than when a patient was recommended to
complete FOBT (67%); showing that universally recommending colonoscopy alone may reduce
adherence to CRC screening (Inadomi, et al., 2012).
Therefore, this project focused on providing tailored CRC educational pamphlets that
included all screening options to patients. Giving patients more information regarding CRC
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screening options and allowing them to make an informed choice concerning CRC screening,
could further increase the number of patients who agree to CRC screening.
Purpose and Objectives
The purpose of this project was to increase the number of patients screened for CRC by
providing tailored CRC and screening education. The overall goal for this project was to increase
the number of CRC screenings in the clinic to increase early detection of polyps and/or CRC
leading to improved prognosis.
Specific Aims:
1) Provide CRC education to 50 to 75-year-old patients at the clinic who are not currently up to
date on screening guidelines.
2) Evaluate the effects of tailored CRC patient education on the total number of CRC screenings
completed via chart review within three to four months post education.
3) Assess the changes in knowledge regarding CRC and screening options by administering a
post-test after patient has reviewed the tailored education pamphlet.
Theoretical Framework
The framework used in the formation of this project was Pender’s Health Promotion
Model, which focuses on background influencers of health decisions. Three main components of
the model include individual characteristics/experiences, behavior-specific cognition, and
behavioral outcomes/health promoting behavior (Pender, 2011).
Individual characteristics/experiences refer to personal factors that influence health
decisions including age, race, socioeconomic status, and prior health behaviors (Pender, 2011).
This can be seen in this project by the patients’ prior decisions regarding CRC screening and the
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effects of general characteristics of the individual, as mentioned previously, on whether they
seek CRC screening.
The behavior-specific cognition and affect aspect is derived from many components, but
most influential to this project includes perceived barriers and benefits of the action, as well as
the interpersonal and situational influences (Pender, 2011). This project assessed benefits of
CRC and screening education on completion of CRC screening. Many interpersonal influences
affect the patient’s decision to complete CRC screening, including the family’s attitude and
behaviors towards receiving screening. Situational influences to keep in mind with this project
and CRC screening include the communities and environments in which the patients live. In
some cases, patients have a lack of resources near them to receive a colonoscopy and making
them aware of other screening options could help patients commit to completing CRC screening.
Behavioral outcomes are described as the desired outcome of health decision making
(Pender, 2011). In this project, it was important to educate the patients on long-term outcomes
that will come with completing or declining CRC screening. These outcomes were discussed in
the tailored patient education pamphlet received by patients participating in the project.
Review of Literature
The question that guided the literature review was “In adults, 50 to 75 years, how does
tailored patient education pamphlets on CRC and forms of screening, compared to usual care,
affect the number of patients who receive CRC screening within three to four months?” To
adequately explore this topic multiple databases were used in the search for reliable and relevant
sources. Cochrane Database of Systemic reviews, CINAHL, PubMed, and MEDLINE were all
used in the search for relevant articles related to answering the PICOT question. Within these
databases subject heading and keyword search strategies were used to narrow down the articles
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to best fit the search objective. Multiple search strategies were used to avoid missing relevant
content and subject heading search is not available for all databases (Melnyk and FineoutOverholt, 2019). The keywords used during the search included “Patient education”, “Patient
intervention”, “Increase screening”, “Colorectal cancer screening”, “Increase adherence”, and
“Improve compliance”.
At first, the literature search returned 189 articles. To narrow down the findings, strategic
inclusion and exclusion criteria were used, as well as making keywords more specific. Inclusion
criteria included studies conducted in western countries (such as Canada, the USA, the UK and
Australia), international studies (including those conducted in developing countries), studies
published in English, studies published within the last 10 years, and peer-reviewed
articles/studies. Studies that were excluded from the literature search included studies in a
language other than English as well as studies taken place prior to 2010. A wide array of studies
were included in the literature search, including randomized controlled trials (RCTs), casecontrol studies, interrupted time series, cohort studies, cross sectional studies, observational
studies, piolet studies, cohort study, qualitative study, and quality improvement studies. Eleven
studies met the expanded criteria and were included in the literature review.
Summary and Strength of the Evidence
Of the studies reviewed there were two systematic reviews, one descriptive study, five
randomized control trials, two pilot studies, and one quality improvement evaluation study. The
strength of this evidence was very high with well over half of the evidence coming from a level
one or level two on the quality of evidence hierarchy (Burns, et al., 2012). Sample size was
sufficient, and the qualitative study evaluated a diverse amount of online patient education
materials. All studies focused on screening education interventions and the appropriate age

18

group. A limitation found was that some of the study samples had been skewed, reflecting one
ethnicity more, or the study was limited to a specific ethnicity (Makoul, et al., 2009; Castaneda,
et al., 2020; Roy, et al., 2021). Another limitation noted was the lack of ability to have a true
control group due to ethical reasons (Davis, et al., 2017; Castaneda, et al., 2020; Sriphalop, et al.,
2016; Katz, et al., 2012).
Tailored education was a common theme of many of the studies reviewed. Tailored
education refers to adjusting the education materials to better fit the patient. Education that has
been tailored to the patients was more effective and resulted in a higher likelihood of completing
screening requirements (Roy, et al., 2021; Issaka, et al., 2019). One example is co-created
material, created by a provider and patient, which showed a higher usability among patients and
was the preferred material, allowing the materials to reach adults across many literacy and ethnic
backgrounds (Bashir, et al., 2019; Castaneda, et al., 2020). Health literacy, which is the
understanding of health information and services needed to make well-informed health decisions,
is a common issue among many patients (Healthy People 2030, 2021). According to the National
Library of Medicine nearly 9 out of 10 adults even those who have a high literacy skill have low
health literacy skills in some situations (2021). Most educational material reviewed in the studies
had been written above the recommended 6th grade reading level and missed key components of
education such as risks, barriers, and benefits of screening (Tian, et al., 2014; Rooney, et al.,
2021).
Various types of education were emphasized in the literature review. Printed educational
handouts/brochures revealed that they alone could be sufficient in activating patients to discuss
screening (Sriphalop, et al., 2016; Roy, et al., 2021). Educational brochures used with videos
were an effective educational tool (Katz, et al., 2012). Video education was explored alone and
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was found to have a potential to increase knowledge and willingness to screen (Issaka, et al.,
2019; Makoul, et al., 2009; Issaka, et al., 2019). Combining brochures with web-based education
also resulted in a higher amount of patient/provider discussion regarding screening (Wilkes, et
al., 2013).
Courses and one on one education have also been studied regarding effectiveness in
screening. Educational group classes and one on one sessions were shown to be an appropriate
approach to equipping patients with the knowledge needed to make a decision regarding
screening (Castaneda, et al., 2020; Sakoda, et al., 2020).
Based on the information gathered during the literature search all forms of education
were beneficial and effective and should be chosen depending on the population. Literature also
recognized that educational materials were most effective when tailored to the patient
population. Educational materials containing all essential content and written at or below a 5th
grade reading level were most beneficial to patients.
Current State and Gaps
The current state of the issue is that there is a high prevalence of CRC and a suboptimal
incidence of CRC screening. Gaps noticed throughout the literature review included the limited
number of studies on the effects of patient education regarding CRC screening on increasing the
number of patients screened. Although there was limited research on the impact of patient
education specifically on CRC screening rates, we can gather from other studies that patient
education can have a huge impact on knowledge and overall rates of screenings. Therefore, it is
promising that increasing patient education through tailored educational pamphlets can lead to an
increased rate of CRC screening.
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Another gap noted was the quality of health education material, with most materials
available missing key educational components. To bridge this gap, materials should include all
appropriate CRC education as well as target specific patient populations which could help to
improve screening rates and knowledge. It is also important to ensure that the pamphlets are at
an appropriate reading level for this population, 5th grade reading level is preferred.
Methods
Design
The design of the study was a quasi-experimental practice improvement project using
patient education, a post-test, and a chart review. The intervention implemented was a tailored
educational pamphlet with information regarding multiple types of CRC screening as well as
CRC in general.
Setting
The setting of this project was a Family and Community Medicine (FCM) clinic in
Lexington, Kentucky. The FCM clinic offers primary care and preventive services for all ages,
treating a variety of illnesses and injuries (UK Healthcare, n.d.). This setting was a good fit for
this project because of the number of patients seen as well as the wide variety of patients and
providers.
The values of UK healthcare are diversity, innovation, respect, compassion, and
teamwork which help to guide the behaviors and clinical decision making to provide the best
patient centered care possible (UK Healthcare, n.d.). These values directly support their mission
and commitment to patient care, education, and research (UK Healthcare, n.d.). The vision of
UK healthcare is to be one community committed to creating a healthier Kentucky (UK
Healthcare, n.d.). These values and goals of UK Healthcare align perfectly with this project. By
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providing patients with education regarding CRC screening, rates of screenings will hopefully
improve leading to a healthier Kentucky. Improving CRC screening has also been named as one
of FCM’s strategic quality indicators on which they wanted to focus. Stakeholders involved in
the process of this project included physicians, nurse practitioners, physician assistants, nurses,
medical assistants (MA), and patients.
One site-specific facilitator was the academic/research affiliation of FCM, this aided in
the implementation of this project because all staff and patients were used to implementation of
projects throughout the clinic. The clinic has focused on CRC screening which helped improve
motivation of the staff for their participation in the study as well as to take action to improve
screening rates. A barrier to implementation was staff participation in the intervention
implementation due to the fast pace of the clinic as well as multiple ongoing QI projects. To
lessen the burden on staff, the PI personally distributed of pamphlets to patients who met
inclusion criteria. Another barrier noted was the potential burden of clinic flow disruption during
implementation as the PI entered patients’ rooms for pamphlet delivery. This barrier was
lessened by asking the appropriate staff for permission to enter the patients’ room after the
patient was settled in a room and prior to provider visit.
To further lessen disruption of clinic flow, implementation took place over a short time
frame. All staff were informed of implementation dates in advance. Being a large academic
setting could have also been a barrier to implementation due to other projects being implemented
at the same clinic, which could lead to some staff confusion. Providing clinic staff, specifically
nurses, MA, and providers, with a brief recap of the PI’s plan for implementation every morning
and being present for questions helped overcome both barriers.
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Sample
The sample of this project included patients aged 50 to 75 years who were scheduled for
appointments during the data collection weeks and who were due or overdue for their CRC
screening. All races and genders were included as well as all patients who speak/read Spanish or
English. Patients were excluded if they were under 50 years old or older than 75 years. Those
who were not due for CRC screening were also excluded from the sample. Patient visits that took
place due to acute pain or illness (such as fever or vomiting) were also excluded due to the lack
of wellbeing during the visit. Patients who were unable to read the educational pamphlet due to
developmental delays were also excluded from the project sample. With these inclusion and
exclusion criteria in mind there were 17 subjects who agreed to participate in the project.
Procedure
IRB Approval
This project was a Quality Improvement project covered under a broad IRB approval
related to teaching residents and DNP students how to conduct quality improvement in the
clinical setting. Therefore, this project did not require separate IRB approval.
Description of Intervention
Based on the literature review and the setting of this project, implementation of CRC
screening pamphlets to patients was the chosen educational media to be most feasible. There
were many national CRC screening educational pamphlets available but to ensure that the
material was tailored to the population of the FCM, an educational pamphlet created by the
Kentucky Cancer Program was used for this project. Local information on receiving financial
assistance for screening as well as Kentucky based websites/offices that offer more information
were listed on the pamphlet ensuring that it was tailored to the population of the clinic (Kentucky
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Cancer Program, 2018). The pamphlet also covered what CRC was and symptoms associated
with CRC. A list of available and recommended screening options were also listed on the
pamphlet for review. This pamphlet was available in English and Spanish to expand the number
of patients reached by this intervention (Appendix A; Appendix B).
Measures and Instruments
A short posttest (Appendix C; Appendix D) was attached to the pamphlets. This posttest
covered three questions which included “Were you able to review the pamphlet?”, “Did you
learn anything new regarding CRC or CRC screening options?”, and “What is your likelihood of
completing CRC screening within the next 6 months?”. The first two questions were simple yes
or no questions followed by a Likert scale question for question three. The Posttest was written
at a 5th grade reading level on five by seven cardstock. The font of the text was Times New
Roman 18-point font to make it easily readable by patients. To make this intervention accessible
to more patients, the posttest cards associated with the Spanish pamphlets were written in
Spanish and those attached to the English pamphlets were written in English.
Data Collection
Implementation and data collection took place over a three-week period. At the beginning
of each week a list of age-appropriate patients who met all inclusion criteria were obtained using
Tableau. Tableau is a UKHC resource that allows providers to select their clinic, date, quality
measure, and whether that measure was met. From here a list of patients who met the criteria for
the study was formulated. This list was then compared to the patient schedule on EPIC by the PI
to assess the time of each patients’ appointment. The PI used this list to make a schedule of
eligible patients to ask to participate in the project during their visit.
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During the implementation weeks, the PI visited each of the eligible patients after the
initial rooming process was completed and prior to the provider visit to explain the project.
Before the PI entered the room and during the rooming process the MAs asked the patients for
permission for the PI to come into the room and discuss CRC. After which the PI entered the
room and obtained consent via script to participate in the project. For all of the patients willing to
participate, the PI then explained the pamphlet, asked patient to review the pamphlet while they
waited for their provider, and complete the attached posttest. Patients’ medical record numbers
were written on the back of each posttest to allow for future evaluation of the intervention via
chart review. After completion of the posttest, patients were asked to leave the posttest in the
exam room for collection by the PI after visit. Data was collected from all providers during this
implementation period. The PI was present throughout the three weeks to ensure that all posttests
were collected, and all appropriate patients had the opportunity to participate.
A chart review was also utilized during data collection, which took place four months
post implementation. Charts of patients who participated in the project were reviewed for
demographic patient information (gender, race, and age) and evidence of a completed CRC
screening including what type of screening was completed. A random sample of charts who also
met inclusion criteria and were seen on the implementation dates were also reviewed to assess
demographic information as well as CRC screening completion. This group was used as the
comparison group of patients who only received usual care during their visit.
Limited resources were needed for the implementation of this project. Providers, nurses,
MA, and the PI were the main personnel involved in implementation. Very little technology was
needed for implementation, although, excel spread sheets were utilized for data analysis. The
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educational pamphlet from the Kentucky Cancer Program was free and printed for distribution.
For the printing of pamphlets and posttests a small budget was needed with a total of 60 dollars.
Data Analysis
The data collected during the chart review included demographic data (age,
race/ethnicity, and sex), completion of CRC screening, and which form of screening was
completed. It was also noted during the chart review if a CRC screening was ordered but not
completed by the patient. The measurements were obtained to determine whether tailored CRC
patient education positively impacted the CRC screening rates in the clinic. All analysis was
completed in SPSS, version 25, with the assistance of a statistician. The data analysis process
involved Levene's Test for Equality of Variances, Chi-Square Tests, Descriptive Statistics.
Levene's Test for Equality of Variances was used to analyze the age of participants. Chi-Square
Tests were used to analyze sex, race, and completion of CRC screening of the participants.
Descriptive Statistics was then used to analyze the post-test results. Variables were summarized
using means and standard deviation or frequency distributions when applicable.
Results
Population Demographics
All patients who met the inclusion criteria were asked to participate in the project, of 27
patients asked 17 patients agreed to participated. The demographics of the control and
intervention group (Table 1) were similar among age, although, sex and race differed slightly,
although not significant. The average age for participants was 61 years old for the control and
intervention groups. There were six (40.0%) females and 9 (60.0%) males included in the control
group, while twelve (70.9%) females and five (76.5%) males were included in the intervention
group. Among the control group there were seven (46.7%) white participants and eight (53.3%)
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African American participants. The intervention group consisted of four (23.5%) white
participants and thirteen (76.5%) African American participants.
Post-Test Results
Among the intervention group, results regarding the post-test (Table 2), which was given
to each participant during their visit, was collected. There was a 100% success rate in
participants being able to review the pamphlet. Among those, 88.2% of participants reported that
they learned something new about CRC or CRC screening options. Overall, the participants’
answers regarding their likelihood of completing CRC screening ranged from 0 (not at all) to 10
(very likely), with an average likelihood of 5.59 out of 10. This average likelihood was affected
by the wide range of answers from participants. There were eight participants that rated their
likelihood between 8 and 10 while there were five rating their likely hood between 0 and 1, while
the other four participants fell in the middle range.
Completion Rates
The Completion rates (Table 3) were also evaluated for the control and intervention
groups four months post-intervention. Only 16 out of the 17 participants were evaluated for
completion rates due to the death of a participant. There was no difference in CRC screening
rates between the control and intervention groups (13.3% and 6.3%, respectively; p=.6). Of the
two who received screening in the control group, both had a colonoscopy. The one participant
who completed screening in the intervention group had a Cologuard screening.
Discussion
This study was able to assess whether tailored CRC patient education pamphlets would
increase CRC screening rate among 50-to-75-year old’s seen at the clinic who were due for CRC
screening. The findings of this QI project show that tailored patient education pamphlets did not
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have a significant impact on the rates of CRC screening at this clinic. Although, as discussed
prior, the literature showed that tailored patient education was successful in other screening
areas.
Even though there was no significant increase in CRC screening rates, participants in the
intervention group who received the tailored CRC education pamphlet did report learning
something knew about CRC or screening options. This could in turn increase their likelihood in
the future of receiving CRC screening or could lead to more discussion of CRC screening with
their providers. Although, increased knowledge alone does not result in behavior change,
providers can advocate for behavior change by increasing personal awareness of why the change
needs to occur and discussing how the patient can make the change (Arlinghaus & Johnston,
2017). It is also shown that tailored education is most effective in increasing personal awareness
(Arlinghaus & Johnston, 2017).
Another observation made from the chart review was that among the participants in both
groups, some had CRC screenings ordered although not completed. The only screening option
that was ordered for participants, although not yet been completed, was Cologuard testing (four
in the control group and three in the intervention group). This showed that discussion about CRC
did occur and a decision on testing was made although the patient had not completed the
screening. Lack of completion of Cologuard tests could be due to inadequate time between
ordering, collection, and results.
Behavioral change and putting something into action is hard. In fact, it is a common rule
that people need to hear something seven times before change is usually made (Kruse, 2021).
Research also shows that repeated statements are viewed as more valid possibly because
repetition goes hand in hand with familiarity (Moons, Mackie, & Garcia-Marques, 2009). Thus,
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sustained use of the pamphlet with a focused conversation about CRC screening options is a
consideration.
Strengths of Study
Many strengths were noted in the study which led to ease of implementation and data
collection. First, the clinic was interested in improving CRC screening rates leading to more
interest in the project. The clinic being an educational clinic also gave some strength to the
project because staff and patients were used to taking part in studies and QI initiatives. There
was also little interference with clinic flow since the PI completed all implementation and
encountered the patient during gaps of care between being seen by the nurse and the provider.
Therefore, every effort was made to decrease stress on staff during the implementation process.
Limitations of Study
During the process of this project a few limitations were noted. Educational pamphlets
were only administered to patients on days that the PI was available to be in clinic resulting in a
small sample size. Another limitation of implementation was that there was only one PI
implementing the intervention although multiple qualified patients were scheduled for
appointments at the same time. The PI was unable to see multiple patients who were scheduled
for the same appointment time leading again to a small sample size.
Another limitation noted during data collection was that electronic health records do not
automatically send results for procedures if they were completed outside of the enterprise. This
could have contributed to the low number of documented completed tests. It is possible there is a
slower documentation of screenings that are completed at other enterprises. As noted above,
several Cologuard tests were ordered but not yet “completed”, this could have also been due to
the results not posting yet. Another factor could have been the small timeframe for completion of
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chart review. Four months were allowed following the intervention before completion of the
chart review, this could have been too narrow of a window for completion for some participants.
The COVID-19 pandemic could have also been a limitation on why patients are behind
on screening or did not complete their screenings. Patients could have been less inclined to
complete preventative health screenings due to the presence and fluctuating number of COVID19 cases. Another factor the pandemic could have played in the completion of CRC screening
was the scheduling of colonoscopies. Many elective procedures were postponed during the
pandemic and are just now being rescheduled. It is possible that an increase in screenings is not
yet detectable.
Recommendations for Practice
With the results from this project, some recommendations for practice can be made to
potentially help increase CRC screening rates. The chart review revealed that many patients who
were not up to date on CRC screening had no documentation of any discussion of CRC by the
providers. Therefore, one recommendation that could be made would be to encourage all
providers to document any discussion of CRC or screening with patients. This will allow all
providers caring for this patient to understand what discussion, if any, had been made with this
patient regarding screening. Discussion could be occurring although there is little documentation
of this. It is imperative that any health screening conversation be documented to enhance
continuity of care, quality of care, and follow-up discussions. One consideration to make this
more feasible for providers would be to include a smart phrase during charting or a check box to
indicating discussion had been made.
It is important that more discussion occur with patients regarding CRC screening at every
non-acute visit to help increase the rates of screening. As mentioned previously, it takes seven
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times for a person to fully grasp a concept and act on that information. Discussion at every visit
will help with repetitive communication leading to familiarity of CRC screening and the
potential of increasing CRC screening rates.
One recommendation for practice would be to include the educational pamphlet in
MyChart. Use of the pamphlet did show increased knowledge and could be beneficial for
providers to educate patients. Allowing the patients to review the material outside of the clinic on
their own time. In addition, providers can encourage the patient to contact them for further
discussion or if they have any questions.
Another recommendation that could be beneficial to increasing the CRC screening rates
would be to establish care gap outreach calls. Outreach calls could possibly aid in increasing
CRC screening rates across the clinic as well as increase knowledge of CRC screening options.
Many studies have shown that telephone outreach can increase screening rates and be more
impactful than text messages or letters (Kiran, Davie, Moineddin, & Lofters, 2018; Coronado, et
al., 2021). These calls could be made to every patient who is due or overdue for CRC screening.
The calls could inform the patients that their CRC screening is due and assess whether they are
interested in screening. To go further, during these calls screening options could be discussed
and if the patient is willing their CRC screening of choice could also be scheduled.
Conclusion
Colorectal cancer (CRC) is a leading cause of cancer and death due to cancer, within
Kentucky and the United States as a whole. Yet only 68 percent of people aged 50-75 on average
receive CRC screening (CDC, 2017; American Cancer Society, 2020). Since most colorectal
malignancies are slow growing, regular CRC screening is extremely important. Although
colonoscopy is the gold standard, many patients are hesitant because of the invasive nature of a
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colonoscopy, therefore, all CRC screening options should be explored with patients to increase
their likelihood of screening.
During implementation, patients who met inclusion criteria and participated in the project
were given tailored CRC patient education pamphlets. The effects of tailored CRC patient
education were evaluated three to four months post education. According to the chart review
tailored patient education pamphlets did not make a difference in the CRC screening rates of
participants. The post-test revealed many of participants in the project noted that they did in fact
learn something knew regarding CRC and screening options.
The findings of this QI project show that tailored patient education pamphlets did not
have a significant impact on the rates of CRC screening at this clinic. Although, some
recommendations for practice can be made including improving documentation by providers of
any discussion of CRC or screening with patients. This will allow for better health maintenance
care by making all other future providers aware of prior CRC discussion. Another suggestion is
to establish care gap outreach calls to follow up with patients who do not meet CRC screening
guidelines and discuss possible screening options for that patient. To better address these
recommendations for practice, future projects interested in bridging the gap of inadequate CRC
screenings could focus on assessing the effectiveness of including the pamphlet in MyChart, the
effectiveness of care gap outreach calls compared to tailored pamphlets, improving provider
discussion of CRC screening as well as documentation of discussion made.
Although CRC educational pamphlets were not significantly impactful in this small
study, there is a lot to gain from this project to further improve practice and patient care. Since
this was a small study, it is truly hard to know what the true impacts of tailored patient education
could be on screening rates. When looking at more robust studies evaluating similar
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interventions results show a significant impact, leading one to believe this approach is still
promising and should be considered in the future. With continued focus on CRC screening and
education within projects as well as trial of the recommendations made an increase CRC
screening rates is achievable.
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Tables
Table 1. Demographic characteristics among intervention and control participants

Age
Sex
Female
Male
Race
White
African American

Control (n = 15)
Mean (SD) or n (%)
61.13 (6.85)

Intervention (n = 17)
Mean (SD) or n (%)
61.35 (6.37)

6 (40.0%)
9 (60.0%)

12 (70.9%)
5 (29.4%)

7 (46.7%)
8 (53.3%)

4 (23.5%)
13 (76.5%)
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p
.93
.082
.169

Table 2. Intervention Post-test Results (n = 17)
n (%) or Mean (SD)
Review pamphlet
Yes
No
Learn anything new about CRC or CRC screening
Yes
No
Likelihood to screen in the future (1 -10)

17 (100%)
0 (0%)
15 (88.2%)
2 (11.8%)
5.59 (4.06)
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Table 3. Comparison of screening rates among intervention and control participants
Control (n = 15)
n (%)
Screening completed
No
Yes

Intervention (n = 16)
n (%)

13 (86.7%)
2 (13.3%)

15 (93.8%)
1 (6.3%)

43

p
.60

Appendices
Appendix A: CRC Educational Pamphlet (English)
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Appendix B: CRC Educational Pamphlet (Spanish)
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Appendix C: Posttest of Knowledge (English)
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Appendix D: Posttest of Knowledge (Spanish)
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